STUDY SUCCESS SOLUTIONS
Bridgepoint Clinical partners with research organizations to improve participant engagement, strengthen retention, and expand diversity in clinical trials.
Participant Experience Assessment
​
Bridgepoint Clinical evaluates the participant journey across the clinical trial lifecycle to identify barriers that affect recruitment, engagement, and retention. Through participant interviews, feedback analysis, and review of site processes, we uncover the real-world factors that influence participant decision-making and study participation. These insights help research teams design more participant-centered trials and improve overall study outcomes.
Participant Advocacy & Navigation
​
​Bridgepoint Clinical provides ongoing participant advocacy and navigation services throughout the duration of a clinical trial. Acting as a supportive liaison between participants and research teams, we help participants better understand study expectations, break down complex consent language, and address questions or concerns that arise during participation. Through regular check-ins and open communication, we ensure participants feel informed, supported, and heard while also helping research teams identify and address issues that may impact engagement and retention.
​Diversity & Inclusive Recruitment Strategy
​
Bridgepoint Clinical helps research organizations strengthen diversity in clinical trials by identifying barriers that limit participation among underrepresented populations. We evaluate recruitment strategies, participant messaging, and access challenges to support more inclusive enrollment practices. Our goal is to help research teams expand representation and ensure trials better reflect the communities they serve.
Community Engagement & Trust Strategy
​
​Trust plays a critical role in clinical trial participation. Bridgepoint Clinical helps research organizations develop engagement strategies that strengthen relationships with communities and improve awareness of research opportunities. By identifying barriers to trust and access, we support outreach approaches that encourage more inclusive participation in clinical trials.